Marksans Pharma standalone net profit declines 88.78% in the March 2017 quarter

Sales decline 22.30% to Rs 53.95 crore

Net profit of Marksans Pharma declined 88.78% to Rs 0.57 crore in the quarter ended March 2017 as against Rs 5.08 crore during the previous quarter ended March 2016. Sales declined 22.30% to Rs 53.95 crore in the quarter ended March 2017 as against Rs 69.43 crore during the previous quarter ended March 2016.

For the full year,net profit declined 82.89% to Rs 12.23 crore in the year ended March 2017 as against Rs 71.49 crore during the previous year ended March 2016. Sales declined 39.73% to Rs 215.84 crore in the year ended March 2017 as against Rs 358.13 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales53.9569.43 -22 215.84358.13 -40 OPM %7.4310.41 -11.2129.01 - PBDT3.0812.80 -76 27.58106.39 -74 PBT-0.748.41 PL 12.5891.64 -86 NP0.575.08 -89 12.2371.49 -83

Powered by Capital Market - Live News